StreetAlpha.app
Home › Stocks › ASTH

Astrana Health, Inc. (ASTH)

$31.99
▼ −2.68%
LAST CLOSE · NOV 17

Astrana Health coordinates patient care through physician networks, clinics and technology tools sold to providers and health plans. It last closed at $31.99 on Nov 17, down 2.68% on the day. The average 12-month price target from 3 analysts is $49.33 (+54.2% from the last close), with a high of $53.00 and a low of $45.00. Analyst consensus is Strong Buy, based on the latest ratings from 3 firms (3 buy, 0 hold, 0 sell).

AI Auto Pilots
Is ASTH in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$3.9B
+35.1% vs a year ago
Net income
$53.1M
+457.1% vs a year ago
EPS (diluted)
$1.08
+468.4% vs a year ago
Free cash flow
$99.4M
2.5% margin
Valuation
Market cap
$1.8B
55.8M shares
P/E
29.6
Price over 12 month EPS
Price to sales
0.5
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$396.2M
At Sep 30
Debt
$925.4M
At Sep 30
Shareholder equity
$856.6M
Buybacks
$18.9M
Last 12 months
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $773.9M$773.9MFY2021FY2022: $1.1B$1.1BFY2022FY2023: $1.4B$1.4BFY2023FY2024: $2.0B$2.0BFY2024FY2025: $3.2B$3.2BFY2025

From ASTH's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 6). Last 12 months adds up the four latest quarters.

Last report
Nov 5
2026 · next date not on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
Strong Buy
Based on 3 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Strong Buy
3firms
3 Buy0 Hold0 Sell
Each firm's latest rating on ASTH in the past 90 days
Average 12-month target
$49.33
▲ 54.2% upside

Based on 3 analysts who set a price target on ASTH in the past 90 days. The average target is $49.33, with a high of $53.00 and a low of $45.00, compared with the last close of $31.99.

Low $45.00Avg $49.33High $53.00
Blue marker: last close $31.99
Highest target$53.00
Average target$49.33
Lowest target$45.00
Latest rating changes
NeedhamMaintained
Nov 6Buy$45
Freedom Capital MarketsMaintained
Oct 1Buy$50
OppenheimerInitiated
Sep 15Buy$53
Truist SecuritiesMaintained
Aug 11Buy$55
BarclaysTarget raised
Aug 7Buy$50 → $53
DateFirmActionRatingPrice target
Nov 6NeedhamMaintainedBuy$45
Oct 1Freedom Capital MarketsMaintainedBuy$50
Sep 15OppenheimerInitiatedBuy$53
Aug 11Truist SecuritiesMaintainedBuy$55
Aug 7BarclaysTarget raisedBuy$50 → $53
Loading…

Technical Analysis

ASTH · as of the Nov 17 close · updated after every close
Turning down, nearing oversold

The stock is 11% below its 20 day and 13% below its 50 day average. It is 8% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 37), near oversold. The nearest support is the Pivot S1 at $31.59, and the nearest resistance the Pivot at $32.16.

Short trendBearish
Long trendNeutral
MomentumWeak
StretchNear oversold
VolatilityHigh, 5.9%/day
Key levels
$51.6052 week high+61.3%
$38.45100 day average+20.2%
$36.83Swing high (Sep 28)+15.1%
$36.1750 day average+13.1%
$35.5520 day average+11.1%
$34.41200 day average+7.6%
$32.55Pivot R1+1.8%
$32.16Pivot+0.5%
$31.99Last close
$31.59Pivot S1−1.3%
$18.0852 week low−43.5%
Indicators
RSI (14)36.85Weak, oversold below 30Neutral
MACD-1.31Below its signal lineBearish
Stochastic13.6Near the bottom of its rangeOversold
ADX (14)20.4Weak trend
Williams %R-88.7Oversold below −80, overbought above −20Oversold
CCI (20)-98.0Oversold below −100, overbought above 100Neutral
Rate of change−12.9%Change over 10 sessionsBearish
ATR (14)$1.90Typical daily range, 5.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for ASTH

What happened before

See how ASTH did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow ASTH usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How ASTH has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2009.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in ASTH in the last 90 days.

Loading…

See today’s whale options flow across the market →

ASTH Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ●110 buying vs 97 selling
  • ▲Held by funds +4.2 pts
  • ▲Funds holding +6
  • ▲Superinvestors: 2 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding218212+2.8%
In funds' top 1012−50.0%
Held by funds61.8%57.6%+4.2 pts
New / increased32 / 7857 / 83−21.4%
Reduced / sold out70 / 2747 / 18+49.2%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See ASTH institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ASTH is in one of them and how their past ASTH trades turned out.

ASTH in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered ASTH in an article yet. Here's the latest on the wider market.

ASTH Congress Trades

All congress trades →
Trades, 12 months
0
Buys
0
Sells
0
People
0
Last filed Aug 30
Who traded ASTH · since 2025
Latest 2 filings
$100K – $250KTraded Aug 19, 2025Filed Aug 30, 2025
$100K – $250KTraded Aug 19, 2025Filed Aug 30, 2025
PersonTypeAmountTradedFiledDelay
Judy ChuD · CABuy$100K – $250KAug 19, 2025Aug 30, 202511 d
Judy ChuD · CASell$100K – $250KAug 19, 2025Aug 30, 202511 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Astrana Health

Astrana Health is a healthcare company based in Alhambra, California, that coordinates patient care through a network of independent physician groups. These groups take on financial responsibility for the cost of care for patients covered by Medicare, Medicaid and health maintenance organizations. The company also runs clinics and outpatient facilities, including primary care, specialty care, urgent care and imaging centers. It sells management services and its own technology tools to health plans and providers.

Headquarters
Alhambra, CA